S&P 500   3,241.24 (+0.13%)
DOW   26,770.48 (+0.03%)
QQQ   266.22 (+0.78%)
AAPL   108.98 (+1.74%)
MSFT   203.92 (+1.66%)
FB   250.68 (+0.67%)
GOOGL   1,433.06 (+1.68%)
AMZN   3,058.82 (+1.97%)
NVDA   498.98 (+2.89%)
TSLA   379.34 (-0.27%)
BABA   270.36 (-0.95%)
CGC   14.36 (-1.64%)
GE   6.09 (-0.33%)
MU   49.65 (-0.40%)
AMD   76.89 (+2.89%)
T   27.97 (+0.36%)
F   6.58 (-0.90%)
ACB   5.22 (+0.97%)
GILD   62.62 (-0.74%)
NFLX   475.95 (+1.13%)
DIS   123.03 (-0.20%)
BAC   23.40 (+0.60%)
BA   148.68 (-1.65%)
S&P 500   3,241.24 (+0.13%)
DOW   26,770.48 (+0.03%)
QQQ   266.22 (+0.78%)
AAPL   108.98 (+1.74%)
MSFT   203.92 (+1.66%)
FB   250.68 (+0.67%)
GOOGL   1,433.06 (+1.68%)
AMZN   3,058.82 (+1.97%)
NVDA   498.98 (+2.89%)
TSLA   379.34 (-0.27%)
BABA   270.36 (-0.95%)
CGC   14.36 (-1.64%)
GE   6.09 (-0.33%)
MU   49.65 (-0.40%)
AMD   76.89 (+2.89%)
T   27.97 (+0.36%)
F   6.58 (-0.90%)
ACB   5.22 (+0.97%)
GILD   62.62 (-0.74%)
NFLX   475.95 (+1.13%)
DIS   123.03 (-0.20%)
BAC   23.40 (+0.60%)
BA   148.68 (-1.65%)
S&P 500   3,241.24 (+0.13%)
DOW   26,770.48 (+0.03%)
QQQ   266.22 (+0.78%)
AAPL   108.98 (+1.74%)
MSFT   203.92 (+1.66%)
FB   250.68 (+0.67%)
GOOGL   1,433.06 (+1.68%)
AMZN   3,058.82 (+1.97%)
NVDA   498.98 (+2.89%)
TSLA   379.34 (-0.27%)
BABA   270.36 (-0.95%)
CGC   14.36 (-1.64%)
GE   6.09 (-0.33%)
MU   49.65 (-0.40%)
AMD   76.89 (+2.89%)
T   27.97 (+0.36%)
F   6.58 (-0.90%)
ACB   5.22 (+0.97%)
GILD   62.62 (-0.74%)
NFLX   475.95 (+1.13%)
DIS   123.03 (-0.20%)
BAC   23.40 (+0.60%)
BA   148.68 (-1.65%)
S&P 500   3,241.24 (+0.13%)
DOW   26,770.48 (+0.03%)
QQQ   266.22 (+0.78%)
AAPL   108.98 (+1.74%)
MSFT   203.92 (+1.66%)
FB   250.68 (+0.67%)
GOOGL   1,433.06 (+1.68%)
AMZN   3,058.82 (+1.97%)
NVDA   498.98 (+2.89%)
TSLA   379.34 (-0.27%)
BABA   270.36 (-0.95%)
CGC   14.36 (-1.64%)
GE   6.09 (-0.33%)
MU   49.65 (-0.40%)
AMD   76.89 (+2.89%)
T   27.97 (+0.36%)
F   6.58 (-0.90%)
ACB   5.22 (+0.97%)
GILD   62.62 (-0.74%)
NFLX   475.95 (+1.13%)
DIS   123.03 (-0.20%)
BAC   23.40 (+0.60%)
BA   148.68 (-1.65%)
Log in
LON:BTG

BTG Share Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume271,742 shs
Average Volume71,114 shs
Market Capitalization£3.26 billion
P/E Ratio29.47
Dividend YieldN/A
BetaN/A
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. The company was formerly known as British Technology Group International plc and changed its name to BTG plc in March 1995. BTG plc was founded in 1948 and is headquartered in London, the United Kingdom.
Read More
BTG logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-75750000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£914.10 million
Book ValueGBX 355.80 per share

Profitability

Miscellaneous

Employees1,631
Market Cap£3.26 billion
Next Earnings DateN/A
OptionableOptionable
30 days | 90 days | 365 days | Advanced Chart

Receive BTG News and Ratings via Email

Sign-up to receive the latest news and ratings for BTG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











BTG (LON:BTG) Frequently Asked Questions

How were BTG's earnings last quarter?

BTG plc (LON:BTG) issued its quarterly earnings data on Tuesday, May, 15th. The company reported $32.90 earnings per share for the quarter, topping analysts' consensus estimates of $29.80 by $3.10.
View BTG's earnings history
.

Who are some of BTG's key competitors?

What other stocks do shareholders of BTG own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BTG investors own include Bodycote (BOY), Rapid7 (RPD), Editas Medicine (EDIT), Portola Pharmaceuticals (PTLA), Tahoe Resources (TAHO), Vectura Group (VEC), Yamana Gold (AUY), Bank of America (BAC), B2Gold (BTO) and Jagged Peak Energy (JAG).

Who are BTG's key executives?

BTG's management team includes the following people:
  • Dr. Louise Makin MA, Ph.D.(Cantab), MBA, DBE, CEO & Exec. Director (Age 58)
  • Mr. Duncan Kennedy A.C.A., B.Sc., CFO & Director
  • Dr. Peter Stratford, Chief Technical Officer & Head of Innovation (Age 52)
  • Mr. Andy Burrows, VP of Corp. & Investor Relations
  • Dr. Paul Mussenden, Gen. Counsel, Head of Strategic Affairs & Company Sec.

What is BTG's stock symbol?

BTG trades on the London Stock Exchange (LON) under the ticker symbol "BTG."

How do I buy shares of BTG?

Shares of BTG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How big of a company is BTG?

BTG has a market capitalization of £0.00 and generates £914.10 million in revenue each year. BTG employs 1,631 workers across the globe.

What is BTG's official website?

The official website for BTG is www.btgplc.com.

How can I contact BTG?

BTG's mailing address is 5 Fleet Place, LONDON, EC4M 7RD, United Kingdom. The company can be reached via phone at +44-20-75750000.

This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.